Ansgar Deibel
Overview
Explore the profile of Ansgar Deibel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robers S, Reinehr M, Haibach L, Furrer E, Cincera A, Kronenberg P, et al.
Histopathology
. 2024 Jul;
85(6):857-867.
PMID: 39044671
Aims: Infections by the larval stage of the tape worms Echinococcus multilocularis and Echinococcus granulosus s.l. are potentially fatal zoonoses affecting humans as dead-end hosts. Histopathological evaluation of hepatic echinococcosis...
2.
Lam L, Soret P, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, et al.
Clin Gastroenterol Hepatol
. 2024 Jul;
22(12):2432-2441.e2.
PMID: 39019421
Background & Aims: In primary biliary cholangitis (PBC), static liver stiffness measurement (LSM) has proven prognostic value. However, the added prognostic value of LSM time course in this disease remains...
3.
Moschouri E, Salemme G, Baserga A, Cerny A, Deibel A, Mullhaupt B, et al.
Swiss Med Wkly
. 2024 Jul;
154(6):3698.
PMID: 38980176
Background And Aim: Direct-acting antivirals (DAAs) have revolutionised the management of chronic hepatitis C. We analysed the use of different generations of DAAs over time in Switzerland and investigated factors...
4.
Morell B, Murray F, Gubler C, Schlag C, Kremer A, Deibel A
Clin Endosc
. 2024 May;
57(5):690-693.
PMID: 38756065
No abstract available.
5.
Muller S, Ghafoor S, Meyer Zu Schwabedissen C, Grimm F, Murray F, Husmann L, et al.
Swiss Med Wkly
. 2023 Nov;
153:40116.
PMID: 37956136
Background And Study Aims: Alveolar echinococcosis, an orphan zoonosis affecting the liver, is of increasing concern worldwide. Most symptomatic cases present at an advanced and inoperable stage, sometimes with biliary...
6.
Maurer A, Kotasidis F, Deibel A, Burger I, Huellner M
Clin Nucl Med
. 2023 Oct;
48(12):1089-1090.
PMID: 37801583
We present dynamic 18 F-FDG PET/CT acquisition in a 52-year-old old woman with histologically proven hepatic alveolar echinococcosis (AE). Metabolic rate of FDG images generated with traditional and relative Patlak...
7.
Corpechot C, Lemoinne S, Soret P, Hansen B, Hirschfield G, Gulamhusein A, et al.
Hepatology
. 2023 Jul;
79(1):39-48.
PMID: 37399238
Background And Aims: Normal alkaline phosphatase (ALP) levels in ursodeoxycholic acid (UDCA)-treated patients with primary biliary cholangitis (PBC) are associated with better long-term outcome. However, second-line therapies are currently recommended...
8.
Kronenberg P, Reinehr M, Eichenberger R, Hasler S, Laurimae T, Weber A, et al.
Front Cell Infect Microbiol
. 2023 Apr;
13:1162530.
PMID: 37009502
Alveolar (AE) and cystic echinococcosis (CE) are severe parasitic zoonoses caused by the larval stages of and , respectively. A panel of 7 monoclonal antibodies (mAbs) was selected against major...
9.
Scheiner B, Roessler D, Phen S, Lim M, Pomej K, Pressiani T, et al.
JHEP Rep
. 2022 Dec;
5(1):100620.
PMID: 36578451
Background & Aims: We investigated the efficacy and safety of immune checkpoint inhibitor (ICI) rechallenge in patients with hepatocellular carcinoma (HCC) who received ICI-based therapies in a previous systemic line....
10.
Husmann L, Gruenig H, Reiner C, Deibel A, Ledergerber B, Liberini V, et al.
Sci Rep
. 2022 Jul;
12(1):11392.
PMID: 35794149
Alveolar echinococcosis is a rare parasitic disease, most frequently affecting the liver, as a slow-growing tumor-like lesion. If inoperable, long-term benzimidazole therapy is required, which is associated with high healthcare...